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Background: Ascent to altitude increases the prevalence of arrhythmogenesis in low-
altitude dwelling populations (Lowlanders). High altitude populations (i.e., Nepalese
Sherpa) may have arrhythmias resistant adaptations that prevent arrhythmogenesis at
altitude, though this has not been documented in other High altitude groups, including
those diagnosed with chronic mountain sickness (CMS). We investigated whether
healthy (CMS-) and CMS afflicted (CMS +) Andeans exhibit cardiac arrhythmias under
acute apneic stress at altitude.
Methods and Results: Electrocardiograms (lead II) were collected in CMS- (N = 9),
CMS + (N = 8), and Lowlanders (N = 13) following several days at 4330 m (Cerro de
Pasco, Peru). ECG rhythm and HR were assessed at both rest and during maximal
volitional apnea. Both CMS- and CMS + had similar basal HR (69 ± 8 beats/min vs.
62 ± 11 beats/min), while basal HR was higher in Lowlanders (77 ± 18 beats/min;
P < 0.05 versus CMS +). Apnea elicited significant bradycardia (nadir −32 ± 15
beats/min; P < 0.01) and the development of arrhythmias in 8/13 Lowlanders (junctional
rhythm, 3◦ atrio-ventricular block, sinus pause). HR was preserved was prior to volitional
breakpoint in both CMS- (nadir −6 ± 1 beat/min) and CMS + (1 ± 12 beats/min), with
2/17 Andeans developing arrhythmias (1 CMS+ and 1 CMS-; both Premature atrial
contraction) prior to breakpoint.
Conclusion: Andeans showed an absence of arrhythmias and preserved HR response
to volitional apnea at altitude, demonstrating that potential cardio-resistant adaptations
to arrhythmogenesis exist across permanent HA populations. Acclimatized Lowlanders
have further demonstrated an increased prevalence of arrhythmias at altitude.
Keywords: hypoxia, Andean, arrhythmia, chronic mountain sickness, electrophysiology, high altitude physiology,
cardiac
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INTRODUCTION
Previous evidence has demonstrated that chronic exposure to
low-oxygen environments [i.e., high-altitude (HA)] increases
the prevalence of arrhythmic events in low-altitude dwelling
populations. Such events have been previously documented in
acclimatized Lowlanders during periods of elevated stress (i.e.,
physical exertion) above 4000 m (Woods et al., 2008; Behn et al.,
2014; Boos et al., 2017). Recently, we demonstrated significant
brady-arrhythmic events were present during a brief bout of
apneic stress in Lowlanders at 5050 m (Busch et al., 2017), but
not native Nepalese Sherpa. Whether the preservation of cardiac
conduction in Sherpa exists amongst other HA population is
unknown. Furthermore, it is unknown if such arrhythmic events
seen in Lowlanders are evident in HA populations susceptible
to chronic mountain sickness (CMS). Andeans have an overall
shorter period of residence at altitude than other HA groups
(Xing et al., 2008; Zhang et al., 2018) in addition to exhibiting
differing physiological adaptation strategies of coping at altitude
than Sherpa (Lahiri et al., 2000; Brutsaert et al., 2005; Beall, 2007;
Hainsworth and Drinkhill, 2007). Furthermore, Andeans exhibit
a higher prevalence of CMS compared with Sherpa (Villafuerte
and Corante, 2016). We therefore investigated whether healthy
(CMS-) and CMS afflicted (CMS +) Andeans exhibit abnormal
cardiac conduction and ectopy.
METHODS
This study was a part of a multi-national research collaboration
in the summer of 2018 to Cerro de Pasco, Peru (4330 m). The
study design was approved by the Clinical Research Ethics Board
of the University of British Columbia (H17-02687 and H18-
01404), the University of Alberta Biomedical Research Ethics
Board (Pro00077330), and the Universidad Peruana Cayetano
Heredia Comité de Ética (number 101686). All participants gave
written, informed consent prior to testing, and were provided a
Spanish translator when necessary.
Participant Recruitment
Seventeen high altitude native Andeans from Peru were recruited
to participate in the study. Andeans without CMS (CMS-)
and current CMS patients (CMS +; N = 8) were all local
residents recruited from either Cerro de Pasco, Peru (4330 m),
or from the surrounding villages. CMS + cutoff criteria included
excessive erythrocytosis (Hb > 21g/dL) and current reported
CMS symptoms [Qinghai CMS Score >6 (Leon-Velarde et al.,
2005)]. CMS + were pre-recruited by a local physician prior to
being recruited to participate. In addition, thirteen Lowlanders
were tested within 3–8 days post-arrival at 4330 m. All Lowlander
participants were members of the research expedition, of
European background, and permanently resided near sea level.
In addition, Lowlanders had not been above 2500 m within
the 3 months prior to arrival at 4330 m. Though no physical
activity patterns were not collected in either Lowlanders or
Andeans, both Lowlanders and CMS- had no known history
of cardiovascular or neurological disease. Two Lowlanders were
reported as having mild acute mountain sickness (3 and 5 on
the 2018 Lake Louise Acute Mountain Sickness Score (Roach
et al., 2018). Both Lowlanders with reported mild AMS were
included in the main analysis due to comparable HR and SpO2
to the main group.
Study Design
All testing and data collection was performed at 4330 m. All
participants abstained from caffeine, alcohol, and strenuous
exercise for 12 h prior to testing. Participants were instrumented
with an electrocardiogram (ECG, lead II; ADInstruments), Heart
rate (HR) was calculated from the ECG R-R interval. Finger Pulse
Oximetry (SpO2; Oximax N-600x, Medtronic), and beat-by-beat
mean (MAP), systolic (SBP), and diastolic (DBP) pressures were
calculated from the arterial pressure waveform that was calibrated
against manual sphygmometer. Following instrumentation, basal
ECG and cardiovascular function was measured during 10 min
of quiet rest prior to attempting a volitional maximal end-
expiratory apnea (to functional residual capacity). Prior to apnea,
an investigator paced the participants’ breathing (2–3 breaths)
to maintain rate and depth, while preventing hyperventilation.
Participants were then instructed to hold their breath for as
long as possible.
Data and Statistical Analysis
HR, SpO2, and BP (Mean ± SD) was averaged during baseline
(1 min pre-apnea attempt) and beat-by-beat for 10 cardiac cycles
prior to volitional breakpoint for apneas. Nadir SpO2 and peak
BP was obtained 10–20 s post-breakpoint. Electrophysiological
characteristics [durations and intervals (Mean ± SD)] of the
ECG were assessed during the last minute immediately preceding
apneas; cardiac cycles (50–75) were over-laid, aligned with the
R-wave and the aggregate was analyzed using automated software
(Chart Pro 8.3.1). To account for variation in apnea duration,
cardiovascular data from the final 10 cardiac cycles of each
apnea were analyzed. A cardiologist (SD) identified and classified
conduction abnormalities from ECG waveforms from the 3 beats
immediately preceding and 3 beats following apnea breakpoint.
HR, BP, and SpO2 was compared through pre-planned contrasts
between CMS-, CMS + and Lowlanders (unpaired T-tests).
An alpha adjustment (α’) for multiple comparisons (c) was
performed by adjusting the a priori alpha (α, 0.05) using the
experiment-wise error rate (αe) (Hinkle et al., 2003):
αe = 1− (1− α)c
a′ = αe
c
Secondary analysis via one-way ANCOVA (SigmaPlot 13.3, Systat
Software, Chicago, IL, United States) was used to control for
duration at altitude in Lowlanders on the degree of bradycardia
exhibited during apnea.
RESULTS
Participant characteristics, cardiovascular function, and ECG
conduction abnormalities are outlined in Tables 1, 2. Participant
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TABLE 1 | Participant characteristics, cardiovascular function, and resting ECG
metrics at rest and during maximal volitional apnea.
Lowlanders Andeans
N = 13
(Female = 4)
CMS−
(N = 9)
CMS+
(N = 8)
Participant characteristics
Age (years) 28 ± 7 45 ± 11† 38 ± 12†
Height (m) 1.74 ± 0.05 1.59 ± 0.04† 1.62 ± 0.05†
Weight (kg) 71 ± 7 68 ± 11 69 ± 12
Body mass index (kg/m2) 23.4 ± 2.1 26.8 ± 4.5† 26.1 ± 3.9†
Resting cardiovascular function
Heart rate (beats/min) 77 ± 18 69 ± 8 62 ± 11†
SPO2 (%) 82 ± 3 80 ± 5 82 ± 1
Systolic blood pressure (mmHg) 128 ± 16 116 ± 12† 113 ± 7†
Diastolic blood pressure (mmHg) 81 ± 8 77 ± 9† 72 ± 4†
Mean arterial pressure (mmHg) 96 ± 10 90 ± 10† 86 ± 3†
Resting ECG metrics
P-wave duration (ms) 100 ± 23 169 ± 117 102 ± 45
PR-Interval (ms) 161 ± 23 239 ± 103† 184 ± 50
QRS duration (ms) 79 ± 15 75 ± 25 85 ± 9
NQTc (ms) 373 ± 77 313 ± 91 343 ± 35
Cardiovascular response to apnea
Apnea duration (s) 13 ± 3 23 ± 8† 33 ± 21†
Heart rate (beats/min) 45 ± 10* 63 ± 11† 63 ± 15†
SPO2 nadir (%)  79 ± 4* 74 ± 5* 78 ± 3*
Systolic blood pressure peak (mmHg)  164 ± 20* 138 ± 16*† 137 ± 11*†
Diastolic blood pressure peak (mmHg)  100 ± 6* 95 ± 8* 92 ± 9*†
Mean arterial pressure peak (mmHg)  122 ± 9* 108 ± 9*† 108 ± 7*†
NFramingham correction (QT + 0.154*(1-RR).  Nadir/Peak response obtained
from post-apnea breakpoint. * Significantly different from baseline; p < 0.05.
† Significantly different from Lowlanders; p < 0.05.
HR responses during the last 10 cardiac cycles preceding apnea
breakpoint are presented in Figure 1. Baseline HR and SpO2
was similar between CMS- (69 ± 8 beats/min; 80 ± 5%) and
CMS + (62 ± 11 beats/min; 82 ± 1%). ECG analysis showed
that CMS-/ + had comparable P-wave (169 ± 117 versus
102 ± 45 ms), PR- interval (239 ± 103 versus 184 ± 50 ms),
QRS (75 ± 25 versus 85 ± 9 ms), and QTC (313 ± 91
versus 343 ± 35 ms) durations. One CMS + exhibited a
Wandering atrial pacemaker during baseline. Apnea duration
and SpO2 desaturation were similar between CMS- (23 ± 8 s;
range 12–32 s; 78 ± 3%) and CMS + (33 ± 21 s; range
11–72 s; 74 ± 5%), while HR was preserved in both groups
(−6 ± 1 and + 1 ± 12 beats/min; p = NS). CMS + and
CMS- had lower MAP, SBP, and DBP at rest but the increase in
pressure during apnea was similar between groups (Table 1). One
CMS- developed a premature Atrial/Junctional escape prior to
breakpoint (Table 2).
Lowlander baseline SpO2 (82 ± 1%) was similar to
Andeans, while HR (77 ± 18 beats/min) was higher versus
CMS + (P < 0.05). Resting ECG metrics in Lowlanders
showed that P-wave (100 ± 23 ms), QRS (75 ± 25 ms),
and QTC (373 ± 77 ms) durations were all similar to
Andeans, while PR-Interval (161 ± 23 ms) was shorter in
TABLE 2 | ECG Abnormalities in Andeans and Lowlanders at 4330 m at rest
and during apnea.
Lowlanders Andeans
(N = 13) CMS−
(N = 9)
CMS +
(N = 8)
ECG abnormalities identified at rest
Ectopy
Junctional rhythm 1 – –
Wandering atrial pacemaker 1 – –
Conduction block
1◦ Atrio-ventricular block 1 – 1
ECG abnormalities identified during apnea**
Ectopy
Premature atrial contraction – 1 1
Premature ventricular contraction 2 – –
Ectopic atrial rhythm 1 – -
Sinus node dysfunction
Sinus pause/arrest 1 – –
Sinus pause/arrest with junctional Escape 4 – –
Conduction block
1◦ Atrio-ventricular block 1 – –
3◦ Atrio-ventricular block 1 – –
ECG assessment was carried out by a cardiologist (SD) who was blinded to
group and condition. ** Conduction abnormalities during apnea occur preceding
or following (<3 beats) breakpoint. All measurements were taken using a standard
lead II configuration.
Lowlanders compared to CMS- (P < 0.05). Arrhythmias were
detected in two Lowlanders during baseline, with one Lowlander
exhibited a wandering atrial pacemaker with a 1◦A-V block
during baseline, while another showed a consistent junctional
rhythm. Apnea attempts in Lowlanders (13 ± 3 s; range 11–
20 s) were shorter than both CMS ± (P < 0.01), though
Lowlander SpO2 nadir (79 ± 4%) was comparable. The post-
apnea peak pressor response was higher in Lowlanders (MAP,
and SBP; P < 0.01) than both CMS + /CMS- Andeans while
DBP was only significantly lower in CMS + (P < 0.01).
Lowlanders also showed significant bradycardia preceding
breakpoint (−32 ± 15 beats/min; P < 0.001 versus baseline;
P < 0.001 versus CMS-/CMS +). Prior to volitional breakpoint
eight Lowlanders developed brief arrhythmic episodes (Figure 2).
These arrhythmic events were categorized into either ectopic
events [premature ventricular contractions (N = 2) and
ectopic atrial rhythm (N = 1)], sinus node dysfunction [sinus
pause/Arrest either with (N = 4) or without (N = 1) junctional
escape], or atrio-ventricular conduction (A-V) blocks (N = 1).
The one Lowlander with 1◦A-V block during baseline also had
a 1◦A-V block during apnea that progressed to a 3◦A-V block
immediately preceding breakpoint.
DISCUSSION
This study reports that Andeans both with and without
CMS exhibit a minimal incidence of arrhythmogenesis
and preserved HR response to apneic stress at altitude.
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FIGURE 1 | Absolute heart rate response (delta change) during maximal
end-inspiratory apnea within Lowlanders (gray circle; N.13), Andean controls
(CMS-: black circle; N.9), and Andean CMS patients (CMS +; white circle;
N.8). The baseline HR for each group at 4330 m (represented as “0
beats/min”) and nadir response (lowest beats/min obtained during the last 10
cardiac cycles) have also been identified. Lowlanders developed significant
bradycardia response prior to volitional breakpoint while both Andean controls
and CMS patients had a preserved heart rate response. * Significant
difference between cardiac cycle and baseline, P < 0.05. † Significant
difference from Lowlanders, P < 0.05.
In addition, Andeans also exhibited a lower peak brachial
pressure post-apnea and near doubling of apnea duration
compared to Lowlanders, despite similar nadir SpO2 post-
breakpoint. We believe these findings demonstrate that both
ventilatory drive and cardiac vagal innervation was lower in
Andeans during apnea. However, the absence of abnormal
cardiac conduction during apnea in CMS + was striking
given that CMS often promotes cardiac remodeling through
a series of hypoxemia induced physiological adaptations
including excessive erythrocytosis, hyperviscosity, impaired
blood flow and pulmonary hypertension, eventual right
atrial/ventricular hypertrophy, and altered ECG pattern
(altered QRS complex/T-wave) (Dante and Arias-Stella, 2007;
Xing et al., 2008; Villafuerte and Corante, 2016). Within our
findings though there was no noted difference in QRS duration
between Andeans and Lowlanders. Assessment of cardiac
structure and function was not performed in the current
study, which prevents us from confirming whether there were
differences present between the healthy Andean participants
and CMS patients. One consideration in our CMS + group
was that the majority of participants displayed only mild CMS
symptoms, with comparable oxygen saturation to both healthy
Andeans and partially acclimatized Lowlanders, regardless
of the evident excessive erythrocytosis. We therefore cannot
comment on whether arrhythmias become evident under more
severe cases of CMS.
The minimal incidence of brady-arrhythmias and preserved
HR response in Andeans are consistent with our previous
findings from indigenous Nepalese Sherpa (Busch et al.,
2017) and further demonstrates an absence of vagal-induced
arrhythmogenesis in HA populations. However, the current study
also showed Andeans had overall longer apnea durations than
Sherpa. As both groups performed maximal apnea attempts
at functional residual capacity, the difference between groups
may in part be explained through Andeans exhibiting a
reduced ventilatory drive (via blunted chemoreflex sensitivity)
to hypoxia stimuli (Severinghaus et al., 1966; Beall, 2007).
We believe the peripheral chemoreceptors plays a considerable
role in the genesis of significant sympatho/vagal conflict
to the heart (Busch et al., 2017). Previous publications
also demonstrate ventilatory drive differs between highland
groups (Beall et al., 1997; Brutsaert et al., 2005), with
Andeans often demonstrating a blunted ventilatory response.
Furthermore, progressive changes in carotid body morphology
(Arias-Stella and Valcarcel, 1976; Lahiri et al., 2000) suggest
gradual chemoreflex desensitization overtime in Andeans.
However, one consideration of the current study is that
HR variation prior to volitional breakpoint was similar
between Sherpa and Andeans which contradicts differences
in ventilatory drive observed each highlander group. Though
outside the scope of the current study, there may be
differential regulation between ventilatory and cardiac autonomic
control in highlander groups which is not explained through
chemoreflex sensitivity. Furthermore, it is unknown whether
the absence of apnea-induced arrhythmias in HA populations
are due to an overall lower degree of cardiac sympatho/vagal
innervation to the heart, or alterior underlying physiological
mechanisms that are specifically cardio-protective to altered
vagal drive. Although Andeans and Sherpa exhibited similar
HR responses and an absence of arrhythmogenesis during
apnea, the underlying physiological mechanisms potentially
differ between HA populations. Further investigation is therefore
required to confirm the current findings in other HA residing
populations (i.e., Native Ethiopian Highlanders) alongside the
underlying physiological differences that cause an absence of
arrhythmogenesis under apneic stress.
The presence of significant brady-arrhythmic events further
demonstrate that Lowlanders exhibit abnormal cardiac
conduction when under apneic stress at altitude. These
events do not appear to be of a baroreflex origin as brachial
pressure increased similarly in Lowlanders and Andeans during
apnea, though Lowlanders had an overall larger increase in
post-apnea peak BP than Andeans. We postulate that the
brady-arrhythmic responses in Lowlanders during apnea are
attributed to conflicting sympathetic/vagal co-innervation
(Shattock and Tipton, 2012) that is compounded with both
altitude-induced sympathetic hyperactivity (Hansen and
Sander, 2003; Lundby et al., 2017; Simpson et al., 2019) and
pre-existing hypoxic stress. This conflict likely becomes more
evident through progressive chemoreflex hypersensitivity
during longer-term residency at altitude (Dempsey et al.,
2014) and ascent. Previously, supplemental oxygen (FiO2 1.00)
has abolished these events during apnea at 5050 m (Busch
et al., 2017), demonstrating the peripheral chemoreceptors
likely play a considerable role. However, any considerable
autonomic stress (Woods et al., 2008; Boos et al., 2017) appears
to be capable of evoking arrhythmogenesis independent of
significant chemoreflex activation, though further research
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FIGURE 2 | ECG recordings of Lowlanders identified with brady-arrhythmias during apnea (N.8) at 4330 m. Each frame (A–H) represents a single participant
recording obtained preceding and/or proceeding volitional breakpoint. (A) sinus pause with junctional escape following volitional breakpoint; (B) ectopic atrial rhythm
with junctional escape that began prior to volitional breakpoint and continued four beats following breakpoint; (C) premature atrial rhythm around volitional
breakpoint; (D) sinus pause (4.3 s) immediately preceding volitional breakpoint; (E) ventricular bigeminy following breakpoint and 1st degree heart block (developed
into 3rd degree); (2F) ventricular escape rhythm prior to volitional breakpoint; (G) premature ventricular contractions developed following breakpoint; (H) sinus pause
with junctional escape preceding volitional breakpoint.
is required. Although these events were benign in healthy
Lowlanders, future direction should be focused on clinical
populations at greater risk of adverse complications arising
from arrhythmogenesis at altitude, including conditions
where consistent cardiac vagal innervation may occur
such as sleep disordered breathing (i.e., Cheyne-Stokes
respiration) (Cummings and Lysgaard, 1981) commonly
observed at altitude.
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Considerations and Limitations
This study has several considerations that should be
acknowledged. As previously mentioned there was no assessment
of cardiac structure and function independent of resting
ECG metrics in the current study, which limits our ability
to determine whether any cardiac abnormalities existed in
CMS patients. This would be an important consideration for
future expeditions to pursue in order to determine if those
exhibiting impaired cardiac function show a higher prevalence
of brady-arrhythmias. Another consideration is participant
recruitment, with Lowlanders consisting of research members
involved in the expedition and all Andeans being locally recruited
from around Cerro de Pasco. Due to the constraints of an
expedition setting Lowlanders were tested on days 3–8 post-
arrival at 4330 m. As of this study, the exposure duration and
minimum altitude necessary to promote arrhythmogenesis is
not currently known, though previous findings suggest that
they are more likely during the transition from acute hypoxia
exposure to longer duration travel at altitudes above 4000 m
(Cummings and Lysgaard, 1981; Woods et al., 2008; Behn
et al., 2014; Brooks et al., 2017; Busch et al., 2017). Though
the duration of the testing period in the current study aligns
with the testing periods of Lowlanders from our previous
work (Busch et al., 2017), the time course for the development
of conduction abnormalities will need to be addressed on
future expeditions.
One final consideration is the noted age difference between
Lowlanders and Andeans. Previous findings (Behn et al., 2014)
suggest that younger low-altitude dwelling individuals may be
more likely to develop arrhythmias at altitude due to greater
underlying vagal drive. Though Lowlanders in the current
study were on average younger than Andeans, we do not
believe that age played a significant factor in our results.
Not only was the degree of bradycardia markedly greater in
Lowlanders prior to volitional breakpoint than Andeans (see
Figure 1 and Supplementary Figure S1), but an additional
post hoc ANCOVA incorporating age as a covariate still noted
differences in the degree of bradycardia between groups during
apnea. Furthermore, arrhythmias were not solely present in our
(younger) lowlander population, as one Lowlander (age 50) and
one EE- (age 62) who developed arrhythmia prior to breakpoint
(sinus pause with junctional escape and premature atrial beat,
respectively). Both individuals being the oldest of their respective
groups. Finally, the current findings support our conclusion that
Highlanders do not exhibit brady-arrhythmias, given almost all
of Andean participants, including younger individuals, exhibited
a minimal incidence of brady-arrhythmias compared to a high
occurrence in Lowlanders.
In summary, these findings demonstrate Andeans with or
without mild CMS exhibit an absence of arrhythmic events that
is akin to Nepalese Sherpa, though the underlying physiological
mechanisms remain to be uncovered. It is important to
note though that the absence of arrhythmia in Andean
CMS + patients would merit from further investigation into
more severe cases of CMS. Regardless, the absence of such
events may be beneficial to surviving at high altitude, as
Lowlanders exhibit a greater risk of developing abnormal
cardiac conduction at altitude under a variety of stressors
at altitude. In future research expeditions we recommend
that in addition to studying the possible duration factor
on when arrhythmogenesis develops in Lowlanders, other
interventions be explored relative to travel at altitude that might
uncover arrhythmias.
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